BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Sinus

Expert replies
by clar » Wed Jul 08, 2009 11:43 pm
Advertisement: Of the many over-the-counter medications marketed for the relief of sinus headache. SineEase costs the least per dose. And SineEase is as effective per dose as the most effective of those other medications. So for relief from sinus headaches, SineEase is the best buy.

Which of the following, if true, most seriously weakens the argument above?

(A) Most of the over-the-counter medications marketed for the relief of sinus headache are equally effective per dose in providing such relief.
(B) Many of the over-the-counter medications marketed for the relief of sinus headache contain the same active ingredient as SineEase.
(C) People who suffer from frequent sinus headaches are strongly advised to consult a doctor before taking any over-the-counter medication.
(D) An over-the-counter medication that is marketed for the relief of symptoms of head cold is identical in composition to SineEase but costs less per dose.
(E) The per dose price for any given over-the-counter medication marketed for the relief of sinus headache is higher for smaller packages than it is for larger packages.

OA D

IMO choice 'D' is irrelevant becoz it compares a drug head cold and sinus . can someone explain the answer?
Join the discussion
Source: — Critical Reasoning |

by gmat740 » Thu Jul 09, 2009 4:53 am
Hey IMO-C

What is the source??
Join the discussion

by clar » Thu Jul 09, 2009 4:58 am
this is from a LSAT doc..

the ans is D
Join the discussion

by graghukalyan » Thu Jul 09, 2009 6:41 am
I am caught between D & E.

IMHO - E it has to be E as there is not linkage between head-cold and sinus.
Join the discussion

by cameronwu » Thu Jul 09, 2009 8:21 am
I got D.

E is irrelevant - packaging has nothing to do with anything - this answer relates price to package, not price or package to effectiveness. You need an element of effectiveness to weaken the conclusion - which is that SineEase is the most effective for the price.

C - consulting a doctor doesn't weaken the conclusion that SineEase is a best buy.

B - Proves nothing. That's like trying to say "I'm as good at basketball as Michael Jordan because we both have active limbs in 2 arms and 2 legs."

A - This proves nothing because it pretty much restates one of the claims in the stimulus - that most sinus medications have equal effectiveness. Since it doesn't speak to the price, and we know that SineEase costs the lease per dose in its class of products, it doesn't weaken the conclusion.

D has to be the answer because it gives an alternative effectiveness to SineEase. The conclusion in the stimulus is that SineEase is the best buy, but in answer choice D, it suggests that head cold medicine has the exact same composition but at a lesser price, which would most seriously weaken the given conclusion. SineEase is the cheapest per dose in "medications marketed for the relief of sinus headache." The conclusion specifically says "For relief from sinus headaches, SineEase is the best buy." If you can show that another medicine will relieve sinus headaches just as effectively but for a cheaper price, such as D, then it weakens the conclusion. It doesn't matter that it's a head cold medicine because the stimulus concludes that it's the best value for sinus headaches period, not just within medicines marketed for sinus headache.
Join the discussion

by james33 » Sun May 15, 2016 8:29 pm
I am pretty sure that the right Answer is D
Join the discussion